Literature DB >> 25250685

Serum protein profiling of adults and children with Crohn disease.

Anna Vaiopoulou1, Maria Gazouli, Aggeliki Papadopoulou, Athanassios K Anagnostopoulos, George Karamanolis, George E Theodoropoulos, Amosy M'Koma, George T Tsangaris.   

Abstract

OBJECTIVES: Crohn disease (CD) and ulcerative colitis (UC), known collectively as inflammatory bowel diseases (IBDs), are chronic immunoinflammatory pathologies of unknown aetiology. Despite the frequent use of biomarkers in medical practice, there is a relative lack of information regarding validated paediatric biomarkers for IBD. Furthermore, biomarkers proved to be efficacious in adults are frequently extrapolated to the paediatric clinical setting without considering that the pathogenesis of many diseases is distinctly different in children. In the present study, proteomics technology was used to monitor differences in protein expression among adult and young patients with CD, identify a panel of candidate protein biomarkers that may be used to improve prognostic-diagnostic accuracy, and advance paediatric medical care.
METHODS: Male and female serum samples from 12 adults and 12 children with active CD were subjected to 2-dimensional gel electrophoresis. Following the relative quantitation of protein spots exhibiting a differential expression between the 2 groups by densitometry, the spots were further characterized by matrix-assisted laser desorption tandem time-of-flight mass spectrometer. The results were confirmed by Western blot analysis.
RESULTS: Clusterin was found to be significantly overexpressed in adults with CD, whereas ceruloplasmin and apolipoprotein B-100 were found to be significantly overexpressed in children, indicating that the expression of these proteins may be implicated in the onset or progression of CD in these 2 subgroups of patients.
CONCLUSIONS: Interestingly, we found a differential expression of several proteins in adults versus paediatric patients with CD. Undoubtedly, future experiments using a larger cohort of patients with CD are needed to evaluate the relevance of our preliminary findings.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25250685      PMCID: PMC4276513          DOI: 10.1097/MPG.0000000000000579

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  48 in total

Review 1.  IBD across the age spectrum: is it the same disease?

Authors:  Joannie Ruel; Darren Ruane; Saurabh Mehandru; Corinne Gower-Rousseau; Jean-Frédéric Colombel
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-12-17       Impact factor: 46.802

2.  Younger age at diagnosis is associated with panenteric, but not more aggressive, Crohn's disease.

Authors:  Eran Israeli; John D Ryan; Leigh-Anne Shafer; Charles N Bernstein
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-20       Impact factor: 11.382

3.  Increased levels of lipoprotein (a) in Crohn's disease: a relation to thrombosis?

Authors:  I E Koutroubakis; N Malliaraki; E Vardas; E Ganotakis; A N Margioris; O N Manousos; E A Kouroumalis
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-12       Impact factor: 2.566

4.  Inflammatory bowel disease in pediatric and adolescent patients: a biomolecular and histopathological review.

Authors:  Luciana Rigoli; Rosario Alberto Caruso
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

5.  Expression of clusterin in Crohn's disease of the terminal ileum.

Authors:  N Gassler; F Autschbach; G Heuschen; R Witzgall; H F Otto; N Obermüller
Journal:  Histol Histopathol       Date:  2001-07       Impact factor: 2.303

6.  Role of ceruloplasmin in inflammation: increased serum ceruloplasmin levels during inflammatory conditions and its possible relationship with anti-inflammatory agents.

Authors:  V K Deshmukh; P H Raman; J N Dhuley; S R Naik
Journal:  Pharmacol Res Commun       Date:  1985-07

Review 7.  Diagnosis and classification of Crohn's disease.

Authors:  Martin W Laass; Dirk Roggenbuck; Karsten Conrad
Journal:  Autoimmun Rev       Date:  2014-01-11       Impact factor: 9.754

8.  Epidemiology of inflammatory bowel diseases: new insights from a French population-based registry (EPIMAD).

Authors:  Corinne Gower-Rousseau; Francis Vasseur; Mathurin Fumery; Guillaume Savoye; Julia Salleron; Luc Dauchet; Dominique Turck; Antoine Cortot; Laurent Peyrin-Biroulet; Jean Frédéric Colombel
Journal:  Dig Liver Dis       Date:  2012-10-27       Impact factor: 4.088

9.  Serum protein profile of Crohn's disease treated with infliximab.

Authors:  Maria Gazouli; Athanasios K Anagnostopoulos; Aggeliki Papadopoulou; Anna Vaiopoulou; Konstantinos Papamichael; Gerassimos Mantzaris; George E Theodoropoulos; Nicholas P Anagnou; George Th Tsangaris
Journal:  J Crohns Colitis       Date:  2013-04-03       Impact factor: 9.071

10.  NADPH oxidase complex and IBD candidate gene studies: identification of a rare variant in NCF2 that results in reduced binding to RAC2.

Authors:  Aleixo M Muise; Wei Xu; Cong-Hui Guo; Thomas D Walters; Victorien M Wolters; Ramzi Fattouh; Grace Y Lam; Pingzhao Hu; Ryan Murchie; Mary Sherlock; Juan Cristóbal Gana; Richard K Russell; Michael Glogauer; Richard H Duerr; Judy H Cho; Charlie W Lees; Jack Satsangi; David C Wilson; Andrew D Paterson; Anne M Griffiths; Mark S Silverberg; John H Brumell
Journal:  Gut       Date:  2011-09-07       Impact factor: 23.059

View more
  8 in total

Review 1.  Current application of proteomics in biomarker discovery for inflammatory bowel disease.

Authors:  Patrick Py Chan; Valerie C Wasinger; Rupert W Leong
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

Review 2.  Proteomics in Inflammatory Bowel Disease: Approach Using Animal Models.

Authors:  Fadi H Mourad; Yunki Yau; Valerie C Wasinger; Rupert W Leong
Journal:  Dig Dis Sci       Date:  2017-07-17       Impact factor: 3.199

3.  Serum Proteomic Signatures of Male Breast Cancer.

Authors:  Eleni Zografos; Athanasios K Anagnostopoulos; Aggeliki Papadopoulou; Evangelia Legaki; Flora Zagouri; Evangelos Marinos; George T Tsangaris; Maria Gazouli
Journal:  Cancer Genomics Proteomics       Date:  2019 Mar-Apr       Impact factor: 4.069

4.  Characteristics of Upper Gastrointestinal Tract Involvement in Korean Pediatric Crohn's Disease: A Multicenter Study.

Authors:  Ji Hyoung Park; Hye Na Nam; Ji-Hyuk Lee; Jeana Hong; Dae Yong Yi; Eell Ryoo; In Sang Jeon; Hann Tchah
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2017-12-22

5.  Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics.

Authors:  Eisuke Miyauchi; Takuya Furuta; Sumio Ohtsuki; Masanori Tachikawa; Yasuo Uchida; Hemragul Sabit; Wataru Obuchi; Tomoko Baba; Michitoshi Watanabe; Tetsuya Terasaki; Mitsutoshi Nakada
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

6.  High-Throughput Identification of the Plasma Proteomic Signature of Inflammatory Bowel Disease.

Authors:  Antonio F Di Narzo; Carrie Brodmerkel; Shannon E Telesco; Carmen Argmann; Lauren A Peters; Katherine Li; Brian Kidd; Joel Dudley; Judy Cho; Eric E Schadt; Andrew Kasarskis; Radu Dobrin; Ke Hao
Journal:  J Crohns Colitis       Date:  2019-03-30       Impact factor: 9.071

7.  Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease.

Authors:  Sara Salvador-Martín; Bartosz Kaczmarczyk; Rebeca Álvarez; Víctor Manuel Navas-López; Carmen Gallego-Fernández; Ana Moreno-Álvarez; Alfonso Solar-Boga; Cesar Sánchez; Mar Tolin; Marta Velasco; Rosana Muñoz-Codoceo; Alejandro Rodriguez-Martinez; Concepción A Vayo; Ferrán Bossacoma; Gemma Pujol-Muncunill; María J Fobelo; Antonio Millán-Jiménez; Lorena Magallares; Eva Martínez-Ojinaga; Inés Loverdos; Francisco J Eizaguirre; José A Blanca-García; Susana Clemente; Ruth García-Romero; Vicente Merino-Bohórquez; Rafael González de Caldas; Enrique Vázquez; Ana Dopazo; María Sanjurjo-Sáez; Luis A López-Fernández
Journal:  Pharmaceutics       Date:  2021-01-08       Impact factor: 6.321

8.  Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease.

Authors:  Sara Salvador-Martín; Irene Raposo-Gutiérrez; Víctor Manuel Navas-López; Carmen Gallego-Fernández; Ana Moreno-Álvarez; Alfonso Solar-Boga; Rosana Muñoz-Codoceo; Lorena Magallares; Eva Martínez-Ojinaga; María J Fobelo; Antonio Millán-Jiménez; Alejandro Rodriguez-Martinez; Concepción A Vayo; Cesar Sánchez; Mar Tolin; Ferrán Bossacoma; Gemma Pujol-Muncunill; Rafael González de Caldas; Inés Loverdos; José A Blanca-García; Oscar Segarra; Francisco J Eizaguirre; Ruth García-Romero; Vicente Merino-Bohórquez; María Sanjurjo-Sáez; Luis A López-Fernández
Journal:  Int J Mol Sci       Date:  2020-05-09       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.